Malignant haem Flashcards

1
Q

how are normal mature cells identified

A

morphology

cell surface antigens (e.g. glycophorin A = red cells)

enzyme expression (e.g. myeloperoxidase = neutrophils)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how are proginators/stem cells identified

A

cell surface antigens - immunophenotyping e.g. CD34

cell culture assays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what happens in malignant haemopoiessi

A

increased numbers of dysfunctional cells and may have loss of the normal haemopoietic reserve

one or more of:
increased prolif
lack of differentiartion
lack of maturation
lack of apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what happens to the cells in acute leukemia

A

abnormal proliferation - large number of similar looking cells
lack of maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

causes of haematological malignancies

A

genetic

enviro

somatic mutations in regulatory genes: driver V passenger mutations [noise]

multiple mutations or can be one single catastrophic event

recurrent cryogenic abnormalities -> contributory rather than the cause of the cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

difference between passenger and driver mutations

A

driver - confer growth advantage, positively selected during the evolution of the cancer

passenger - do not confer growth advantage, happened to be present in an ancestor of the cancer cell when it acquired on of its driver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the concordant rate with twins in ALL

A

10-15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how many people over the age of 65 for driver mutations that are associated with haematological malignancies

A

around 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how can the genetic defect be found in ALL

A

by investigating the guthrie card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal haemopoiesis

malignant haemopoeisis

A

polyclonal

monoclonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

classification of haematological malig

A

acute/chronic presentation - depends on type and stage of defect

anatomical site: -medullary/extramedullary
-leukaemia (blood)/lymphoma

lineage:

  • myeloid
  • lymphoid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of lymphomas

A

high grade - aggressive histology: large primitive cells and clinically aggressive

low grade - generally less aggressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is odd about chronic lymphocytic leukaemia

A

involves not just blood/bone marrow but lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

myeloma is what

A

plasma cell malignancy of the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are acute leukaemia

A

rapidly progressive clonal malignancy of the marrow/blood with maturation defects

excess of blasts >20% in either peripheral blood or bone marrow

decrease/loss of normal haemopoietic reserve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

types of acute leukaemia

A

actual myeloid leu

acute lymphoblastic leu

17
Q

what is ALL

A

malignant disease of lymphocytes

18
Q

who is ALL common in

A

most common childhood cancer

19
Q

presentation of ALL

A

marrow failure - anaemia, infection, bleeding
leukaemia effects - high ECC, nervous system effects, lymph nodes sometimes causing venous obstruction [SVC obstruction]
bone pain - v severe

20
Q

acute myeloid leu more common in who

presentation

A

elderly >60
de novo or secondary
presentation similar to aLL -> doesn’t involve CNS

21
Q

what other ways can some subgroups of AML present

A

DIC

Gum infiltration

22
Q

investigations for acute leu

A

blood count and film - low hb, white cells may be high, low platelets, low neutrophils
film - Auer rods in acute myeloid leukaemia

coag screen

bone marrow aspirate

23
Q

bone marrow aspirate

A

morphology - mononuclear, high nuclear: cytoplasmic ration, very metabolically active

immunophenotype if no auer rods can be seen - CD33 is seen on myeloid cells not lymphoid cells, CD34

cytogenetics - help w dx and prognostic significance

trephine (piece of bone) - better assessment of cells if aspirate sub optimal

24
Q

why is immunophenotyping required or a definitive dx

A

cells from AML and ALL look alike

treatment for both are different

25
treatment for acute leukaemia
multi agent chemo
26
treatment for ALL
lasts for 2-3 years
27
treatment for AML
normally intensive | prolonged hospitalisation
28
hickman line
chemo generally given through a hickman line | goes through the subclavian vein
29
problems of marrow suppression due to treatment
anaemia neutropenia = infections - gran neg can cause fulminant life threatening sepsis in neutropenic px thrombocytopenia - bleeding: purpura, petechiae
30
complications of treatment
``` n+v hair loss liver/renal dysfunction tumour lysis dysfunction - during first course of treatment infection ``` late effects - loss of fertility, cardiomyopathy with anthracycline
31
management of infections due to treatment
bacterial: empirical treatment w broad spec ab as soon as neutropenic fever fungal - if prolonged neutropenia and persisting fever unresponsive to anti bacterial agents protozoal
32
outcome of treatment
most go into remission but depending on the can relapse some will die to treatment related toxicity
33
childhood outcomes of treatment
childhood ALL >85% cure rates Adult ALL 30-40% Adult ALL <60 50% Adult AML >60 <10%
34
what can be given that may be curative after initial therapy or at relapse
allogeneic stem cell transplantation
35
what type of acute leu is assoc with DIC | how is this treated
acute peomyelocytic leuk vitamin and arsenic to treat